Friday, 16 October 202610:59 am ISTIndia edition

Just in

10:19 am"Ready To Go To Jail": CJP's Abhijeet Dipke Ahead Of Protest In Delhi, Mumbai
10:14 amEarthquake Of Magnitude 7 Strikes Russia, Japan Mistakenly Issues 9.9 Warning
10:09 am"We're Done": Zelensky Feels 'Betrayed' By Trump, Ukraine Attacks Russian Refinery
10:06 amTwist In Kerala Extortion Case, Accused's Family Claims Torture
10:01 amIAS officer’s foul language against female officer during meeting goes viral online, sparks protest from J&K officers
SponsoredPut your announcement in this ticker from ₹69/day
9:57 am'Will stand with Pakistan’: BJP leader's remark stokes controversy; Congress cries 'treason', AAP askes PM to respond
9:54 amZelensky rallies European allies as Trump ties slump
9:52 amASDD bulk deletions effected by ECI without due procedure through autogenerated Form-7s signed by EROs
9:51 amColours of life: How this eight hearing-impaired women stitched a new future through skill training in Malappuram
9:50 amDelhi High Court dismisses pleas for SIT probe into 2020 riots, 2019 Jamia violence
9:49 amAbandon Pattinapakkam Assembly-cum-Secretariat complex project, insists PIL plea before Madras High Court
9:48 amWho Is Prem Watsa? Canadian Billionaire Who Left India With $8, Now Betting Rs 52,878 Crore On IDBI Bank
9:47 amSpecial Parliament Session Likely This Month To Pass Women's Quota, Delimitation Bills
9:46 amIAS officer abuses colleague, threatens suspension after she objects: 'I can talk like that, I'm your boss'
10:19 am"Ready To Go To Jail": CJP's Abhijeet Dipke Ahead Of Protest In Delhi, Mumbai
10:14 amEarthquake Of Magnitude 7 Strikes Russia, Japan Mistakenly Issues 9.9 Warning
10:09 am"We're Done": Zelensky Feels 'Betrayed' By Trump, Ukraine Attacks Russian Refinery
10:06 amTwist In Kerala Extortion Case, Accused's Family Claims Torture
10:01 amIAS officer’s foul language against female officer during meeting goes viral online, sparks protest from J&K officers
SponsoredPut your announcement in this ticker from ₹69/day
9:57 am'Will stand with Pakistan’: BJP leader's remark stokes controversy; Congress cries 'treason', AAP askes PM to respond
9:54 amZelensky rallies European allies as Trump ties slump
9:52 amASDD bulk deletions effected by ECI without due procedure through autogenerated Form-7s signed by EROs
9:51 amColours of life: How this eight hearing-impaired women stitched a new future through skill training in Malappuram
9:50 amDelhi High Court dismisses pleas for SIT probe into 2020 riots, 2019 Jamia violence
9:49 amAbandon Pattinapakkam Assembly-cum-Secretariat complex project, insists PIL plea before Madras High Court
9:48 amWho Is Prem Watsa? Canadian Billionaire Who Left India With $8, Now Betting Rs 52,878 Crore On IDBI Bank
9:47 amSpecial Parliament Session Likely This Month To Pass Women's Quota, Delimitation Bills
9:46 amIAS officer abuses colleague, threatens suspension after she objects: 'I can talk like that, I'm your boss'

Business

Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics

Reported by Healthysoch 15 Oct 2026, 9:16 pm IST 1 min read

Business news on The Headline Update

Armed Cell Therapeutics is a Belgium-based biotechnology company developing next-generation armed CAR-T therapies for cancer. India healthysoch New Delhi, October 15, 2026: As a part of its long term strategy to build a global innovation-led pharmaceutical business, Mankind Pharma (BSE: 543904 | NSE: MANKIND) through its subsidiary Mankind Pharma (Netherlands) B.V., has entered into a definitive agreement under which Mankind Pharma will acquire a majority stake in Armed Cell Therapeutics B.V., a Belgium-incorporated biotechnology company developing next-generation CAR-T (chimeric antigen…

Read the full report on Healthysoch

Story file

Section: Business
Topics: Stock market, Health alerts, Cars & bikes
Places: Delhi
First reported by: Healthysoch
Reporter: healthy soch
Published: Thursday, 15 October 2026, 9:16 pm IST
Coverage: One outlet so far

How this page works. The Headline Update lists this report from Healthysoch with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.